Catalyst Wire Dossier Catalyst Wire Dossier

Fablyn

lasofoxifene tartrate · Dr. Friedrich Eberth Arzneimittel GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fablyn, covering 2012-06-21 to 2012-06-21. Get the full timeline:

Most recent: EMA Lapsed: Fablyn (Lasofoxifene tartrate) — Dr. Friedrich Eberth Arzneimittel GmbH

See pricing